Equillium, Inc. (EQ) vs Rallybio Corporation (RLYB)

Equillium, Inc. and Rallybio Corporation are both Biotechnology companies. Equillium, Inc. and Rallybio Corporation are of similar size ($91.3M and $90.2M). Equillium, Inc. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 2.1×. Equillium, Inc. grew revenue faster over the last twelve months: 13.9% against 1.18%. Across the 12 metrics below, Rallybio Corporation leads on 7 and Equillium, Inc. on 5.

Valuation

Metric EQ RLYB Biotechnology median
P/E n/m 2.11 8.68
P/S 3.89 113.05 10.29
P/B 2.85 1.03 2.40
Price to free cash flow n/m 3.64 20.52
EV/EBITDA n/m n/m 0.68
EV/Sales 2.68 4.83 10.15
Earnings yield (13.99%) 47.35% (28.86%)
Free cash flow yield (12.56%) 27.51% (22.44%)

Profitability

Metric EQ RLYB Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (58.98%) 64.86% (56.66%)
Return on assets (50.68%) 61.12% (49.22%)
Return on invested capital 0.00% (1,052.03%) 0.00%

Growth

Metric EQ RLYB Biotechnology median
Revenue growth (TTM) 13.89% 1.18% 5.64%
EPS growth (last fiscal year) (69.57%) 85.06% 30.08%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EQ RLYB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 23.40 27.26 4.72
Net debt to EBITDA 1.29 1.63 0.96

Dividend

Metric EQ RLYB Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric EQ RLYB Biotechnology median
Market cap 91.31m 90.23m 150.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack